September 10, 2025 – By Attorney Martin Schmidt –We’re investigating the rare eye condition known as nonarteritic anterior ischemic optic neuropathy (NAION) that appears to create vision problems from popular weight loss drugs such as Ozempic and/or Wegovy. Reach out to us today if this has happened to you or a loved one. We expect potential large cash settlements from these Ozempic lawsuit claims – Act Today.
Did you develop sudden vision loss after the use of GLP-1 weight loss drugs? The Schmidt National Law Group are currently filing lawsuit injury claims. Use the 100% Secure Ozempic Claim Form on this page and get a free case evaluation today!
Ozempic Claim Form
Did you suffer side effects from Ozempic, Wegovy, or Mounjaro?
"*" indicates required fields
What is the Ozempic Vision Loss Lawsuit about?
Several ongoing legal cases claim that Ozempic and similar GLP-1 medications are connected to a serious eye condition known as Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), which may lead to irreversible blindness. These legal actions, initiated by patients and their legal representatives against pharmaceutical companies such as Novo Nordisk, assert that these manufacturers did not properly disclose the heightened NAION risk, despite existing research indicating this connection.
Page: Ozempic Claim Form | Vision Loss Lawsuits 2025 Updated on September 10, 2025.